Clinical trial
"DOES MYOBLOC™ IMPROVE FUNCTIONAL HAND USE IN YOUNG CHILDREN WITH A HYPERTONIC…
NCT00238641 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00238641 |
|---|---|
| Title | "DOES MYOBLOC™ IMPROVE FUNCTIONAL HAND USE IN YOUNG CHILDREN WITH A HYPERTONIC UPPER EXTREMITY?" |
| Official title | "DOES MYOBLOC™ IMPROVE FUNCTIONAL HAND USE IN YOUNG CHILDREN WITH A HYPERTONIC UPPER EXTREMITY?" |
| Lead sponsor | Stanford University, Other |
| Collaborators | Elan Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Cerebral Palsy |
| Intervention type | Drug |
| Interventions | Botulinum Toxin type B |
| Enrollment | 10 |
| Start date | Jan 1, 2002 |
| Completion | May 1, 2005 |
| First posted | Oct 13, 2005 |
| Last update posted | Oct 13, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: